Regulus Therapeutics Inc. (RGLS) SEC filings

RGLS SEC filings moved a median of +0.38% by the close. RGLS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RGLS overview →

37 measured RGLS SEC filing events.

Where these RGLS SEC filings landedvs 32 measured RGLS SEC filing reactions
RGLS SEC filingMiddle 50% · -4.11% to +4.13%Zero: 0.00%Median: +0.38%Median +0.38%-6.00%0+6.00%
Middle 50% of RGLS SEC filing reactions-4.11% to +4.13%
Median reaction (to close)+0.38%
Measured reactions32
Point-in-time · zero look-ahead

Half of the 32 RGLS SEC filing events with a measured close landed between -4.11% and +4.13%; 53% closed up.

DateHeadlineEvent5-minTo close
Form 15-12G Regulus TherapeuticsSEC filing · Form 15-12G——
Form EFFECT Regulus TherapeuticsSEC filing · Form EFFECT——
Form 8-K Regulus Therapeutics For: Jun 24SEC filing · Form 8-K——
Form POS AM Regulus TherapeuticsSEC filing · Form POS——
Form S-8 POS Regulus TherapeuticsSEC filing · Form S-8——
Form 10-Q Regulus Therapeutics For: Mar 31SEC filing · Form 10-Q+1.15%+0.51%
Form 8-K Regulus Therapeutics For: May 08SEC filing · Form 8-K+1.15%+0.51%
Form 10-K/A Regulus Therapeutics For: Dec 31SEC filing · Form 10-K+0.13%+0.26%
Form 8-K Regulus Therapeutics For: Apr 29SEC filing · Form 8-K-1.38%-0.25%
Form 8-K Regulus Therapeutics For: Mar 27SEC filing · Form 8-K+1.06%+5.63%
Form 10-K Regulus Therapeutics For: Dec 31SEC filing · Form 10-K+0.73%+8.03%
Form 8-K Regulus Therapeutics For: Mar 13SEC filing · Form 8-K+0.73%+8.03%
Form 8-K Regulus Therapeutics For: Feb 28SEC filing · Form 8-K+0.00%+2.27%
Form S-8 Regulus TherapeuticsSEC filing · Form S-8+7.41%+7.53%
Form 10-Q Regulus Therapeutics For: Sep 30SEC filing · Form 10-Q+0.41%-0.68%
Form 8-K Regulus Therapeutics For: Nov 07SEC filing · Form 8-K+0.41%-0.68%
Form 8-K Regulus Therapeutics For: Oct 22SEC filing · Form 8-K+2.19%+1.41%
Form 10-Q Regulus Therapeutics For: Jun 30SEC filing · Form 10-Q-5.77%-5.13%
Form 8-K Regulus Therapeutics For: Aug 08SEC filing · Form 8-K-5.77%-5.13%
Form 8-K Regulus Therapeutics For: Jun 24SEC filing · Form 8-K+10.68%-0.48%
Form S-8 Regulus TherapeuticsSEC filing · Form S-8+0.51%-4.54%
Form 8-K Regulus Therapeutics For: May 16SEC filing · Form 8-K-2.00%+0.50%
Form 10-Q Regulus Therapeutics For: Mar 31SEC filing · Form 10-Q+6.57%+3.76%
Form 8-K Regulus Therapeutics For: May 09SEC filing · Form 8-K+6.57%+3.76%
Form DEFA14A Regulus TherapeuticsSEC filing · Form DEFA14A+0.00%+9.13%
Form EFFECT Regulus TherapeuticsSEC filing · Form EFFECT+1.91%+5.26%
Form ARS Regulus Therapeutics For: Dec 31SEC filing · Form ARS+1.91%+5.26%
Form DEF 14A Regulus Therapeutics For: May 16SEC filing · Form DEF+1.91%+5.26%
Form S-3 Regulus TherapeuticsSEC filing · Form S-3-1.31%-2.24%
Form 10-K Regulus Therapeutics For: Dec 31SEC filing · Form 10-K+0.00%-4.11%
Form 8-K Regulus Therapeutics For: Mar 21SEC filing · Form 8-K+0.00%-4.11%
Form 8-K Regulus Therapeutics For: Mar 11SEC filing · Form 8-K-0.41%-13.17%
Form S-8 Regulus TherapeuticsSEC filing · Form S-8+0.00%-6.30%
Form EFFECT Regulus TherapeuticsSEC filing · Form EFFECT—+3.15%
Form S-3 Regulus TherapeuticsSEC filing · Form S-3—-1.56%
Form 10-Q Regulus Therapeutics For: Sep 30SEC filing · Form 10-Q—-5.71%
Form 8-K Regulus Therapeutics For: Nov 09SEC filing · Form 8-K—-5.71%
That’s how RGLS usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More RGLS: earnings → · analyst actions → · RGLS overview →

Other Healthcare names and their SEC filings

TickerEventsMedian 30-min% positive
Immuron Limited - American Depositary Shares (IMRN)202-0.21%29%
InfuSystems Holdings, Inc. (INFU)2020.00%50%
Daxor Corporation - Closed End Fund (DXR)2000.00%50%
The Joint Corp. (JYNT)2000.00%45%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.